Retinol & Peptide Anti-Ageing Serum - Retinol 0.2% + Peptide 1%

Clean allergen profile with a fragrance free formula.

Retinol at 0.2% is an intermediate concentration, significantly more active than entry-level formulas in the 0.025-0.05% range but below the EU guideline maximum of 0.3% for face products. New retinol users should not start here without prior experience with retinoids. All Vitamin A derivatives carry a mandatory pregnancy contraindication. No synthetic fragrance, no parabens, no sulfates, no alcohol were found. The water-based vehicle is less protective of Retinol stability than an oil-based or anhydrous formula, though Tocopheryl Acetate in the formula provides some antioxidant stabilisation. Opaque or airless packaging is important for Retinol stability and should be verified at the point of purchase.

Niacinamide appears very early in the formula, suggesting a meaningful concentration that would provide barrier support during the Retinol adjustment phase.

Niacinamide appears very early in the formula, suggesting a meaningful concentration that would provide barrier support during the Retinol adjustment phase. Retinol at the brand-confirmed 0.2% and the Peptide complex at the brand-confirmed 1% are both present. Acetyl Hexapeptide-3 appears in the formula with its concentration consistent with the stated 1% peptide complex. Tocopheryl Acetate helps stabilise Retinol against oxidation in the water-based vehicle. Glycerin and Sodium Hyaluronate offset the drying effect that can occur during Retinol introduction. The formula pH is not publicly disclosed, which is relevant context for Retinol stability, since very low pH can degrade Retinol over time.

Good evidence for stated claims based on public information.

Full ingredient list is available on thedeconstruct.in. Retinol at 0.2% and the Peptide complex at 1% are both brand-confirmed. The pregnancy contraindication is communicated on packaging. Deconstruct publishes ingredient education content across its product range, which gives consumers context for how Retinol and Argireline work. The formula pH is not disclosed, and Retinol formula pH affects both stability and consumer experience. No unsupported efficacy claims were identified.

Full INCI available on the brand website.

Full INCI available on the brand website. Both active concentrations confirmed. The pregnancy contraindication is communicated. Ingredient education content is published. No lab test reports, no clinical study, no preservative efficacy test result, and no stability documentation are publicly accessible. Formula pH undisclosed. Grade C: above-average transparency through concentration disclosure and clear safety communication, but no independent third-party testing documentation is publicly visible.

Night-use guidance, gradual introduction advice, application frequency recommendations, and the pregnancy contraindication are communicated.

Night-use guidance, gradual introduction advice, application frequency recommendations, and the pregnancy contraindication are communicated. SPF guidance for morning use after nightly Retinol application is present. One point lost for the absence of specific layering guidance for users combining this with other actives.